Get started
SANOFISANOFISANOFI

SANOFI

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

SNY/N chart


Full chart

Key facts today


Dr. Oliver Brooks received about $44,000 from Sanofi in 2017-2018, failing to disclose potential conflicts of interest affecting his vaccine recommendation votes.
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪2.33 T‬ MXN
Dividend yield (indicated)
3.21%
Price to earnings Ratio (TTM)
21.01
Basic EPS (TTM)
50.11 MXN
Net income (FY)
‪125.39 B‬ MXN
Revenue (FY)
‪926.48 B‬ MXN
Shares float
‪2.44 B‬
Beta (1Y)
0.30

About SANOFI


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Paul Hudson
Website
sanofi.com
Headquarters
Paris
Founded
1994
FIGI
BBG000FSTZC9
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

SNY/N news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

SNY/N highest yielding bonds


US801060AD6
SANOFI SA 18/28
Yield to maturity
4.34%
Maturity date
Jun 19, 2028
FR1332437
SANOFI 18/38 MTN
Yield to maturity
3.53%
Maturity date
Mar 21, 2038
FR1340985
SANOFI 19/34 MTN
Yield to maturity
3.30%
Maturity date
Mar 21, 2034
FR1400Y1I
SANOFI 25/31 MTN
Yield to maturity
2.91%
Maturity date
Mar 11, 2031
FR1332435
SANOFI 18/30 MTN
Yield to maturity
2.73%
Maturity date
Mar 21, 2030
FR1350511
SANOFI 20/30 MTN
Yield to maturity
2.67%
Maturity date
Apr 1, 2030
FR14009KQ
SANOFI 22/29 MTN
Yield to maturity
2.63%
Maturity date
Apr 6, 2029
FR1340984
SANOFI 19/29 MTN
Yield to maturity
2.59%
Maturity date
Mar 21, 2029
FR1314400
SANOFI 16/28 MTN
Yield to maturity
2.34%
Maturity date
Apr 5, 2028
FR1400Y1H
SANOFI 25/27 FLR MTN
Yield to maturity
2.30%
Maturity date
Mar 11, 2027
FR1214680
SANOFI 14/26 MTN
Yield to maturity
2.29%
Maturity date
Sep 10, 2026

See all SNY/N bonds 

Sparks


Curated watchlists where SNY/N is featured.

See all sparks 


Check out other big names from the same industry as SNY/N.